High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation

References

• Aggarwal BB, Harikumar KB. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41:40–59
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18
   PubMed Web of Science ®Google Scholar
• Barreto JA, O’Malley W, Kubeil M, et al. (2011). Nanomaterials: applications in cancer imaging and therapy. Adv Mater 23:25
   Web of Science ®Google Scholar
• Cai Y, Sun Z, Fang X, et al. (2015). Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles. Drug Deliv 16:1–9
   Web of Science ®Google Scholar
• Cao Y, Gao M, Chen C, et al. (2015). Phospholipid-like amphiphilic polymer conjugate micelles for on-demand intracellular curcumin delivery. J Control Release 10:19
   Google Scholar
• Chen Y, Pan L, Jiang M, et al. (2016). Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Drug Deliv 23:1383–92
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu CH, Lin JK, et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–900
   PubMed Web of Science ®Google Scholar
• Chiannilkulchai N, Ammoury N, Caillou B, et al. (1990). Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol 26:122–6
   PubMed Web of Science ®Google Scholar
• Demetzos C, Pippa N. (2014). Advanced drug delivery nanosystems (aDDnSs): a mini-review. Drug Deliv 21:250–7
   PubMed Web of Science ®Google Scholar
• Deng J, Huang L, Liu F. (2010). Understanding the structure and stability of paclitaxel nanocrystals. Int J Pharm 390:242–9
   PubMed Web of Science ®Google Scholar
• Ding Q, Niu T, Yang Y, et al. (2014). Preparation of curcumin-loaded poly(ester amine) nanoparticles for the treatment of anti-angiogenesis. J Biomed Nanotechnol 10:632–41
   PubMed Web of Science ®Google Scholar
• Dong F, Dong X, Zhou L, et al. (2016). Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: preparation, in vitro evaluation, and cellular uptake. Colloids Surf B Biointerfaces 140:324–31
   PubMed Web of Science ®Google Scholar
• Duan Y, Wang J, Yang X, et al. (2015). Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro. Drug Deliv 22:50–7
   PubMed Web of Science ®Google Scholar
• Egan ME, Pearson M, Weiner SA, et al. (2004). Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304:600–2
   PubMed Web of Science ®Google Scholar
• El-Khoury E, Patra D. (2016). Length of hydrocarbon chain influences location of curcumin in liposomes: curcumin as a molecular probe to study ethanol induced interdigitation of liposomes. J Photochem Photobiol B 158:49–54
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Z, Sun M, et al. (2010). Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm 36:1225–34
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Z, Sun M, et al. (2011). Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv 18:131–42
   PubMed Web of Science ®Google Scholar
• Guo O, Li X, Yang Y, et al. (2014). Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(l-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol 10:227–37
   PubMed Web of Science ®Google Scholar
• Han M, Yu X, Guo Y, et al. (2014). Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Colloids Surf B Biointerfaces 116:114–20
   PubMed Web of Science ®Google Scholar
• Hu L, Shi Y, Li JH, et al. (2015). Enhancement of oral bioavailability of curcumin by a novel solid dispersion system. AAPS PharmSciTech 16:1327–34
   PubMed Web of Science ®Google Scholar
• Hu X, Han R, Quan LH, et al. (2013). Stabilization and sustained release of zeylenone, a soft cytotoxic drug, within polymeric micelles for local antitumor drug delivery. Int J Pharm 450:331–7
   PubMed Web of Science ®Google Scholar
• Hu X, Yang FF, Quan LH, et al. (2014). Pulmonary delivered polymeric micelles – pharmacokinetic evaluation and biodistribution studies. Eur J Pharm Biopharm 88:1064–75
   PubMed Web of Science ®Google Scholar
• Jain KK. (2005). Nanotechnology-based drug delivery for cancer. Technol Cancer Res Treat 4:407–16
   PubMed Web of Science ®Google Scholar
• Khan J, Alexander A, Ajazuddin, Saraf S. (2013). Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release 168:50–60
   PubMed Web of Science ®Google Scholar
• Kim SC, Kim DW, Shim YH, et al. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 72:191–202
   PubMed Web of Science ®Google Scholar
• Kim TH, Jiang HH, Youn YS, et al. (2011). Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–91
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Anand P, Aggarwal BB. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225
   PubMed Web of Science ®Google Scholar
• Kurd SK, Smith N, Vanvoorhees A, et al. (2008). Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol 58:625–31
   PubMed Web of Science ®Google Scholar
• Lee WH, Bebawy M, Loo CY, et al. (2015). Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activity. J Biomed Nanotechnol 11:1093–105
   PubMed Web of Science ®Google Scholar
• Lou H, Zhang X, Gao L, et al. (2009). In vitro and in vivo antitumor activity of oridonin nanosuspension. Int J Pharm 379:181–6
   PubMed Web of Science ®Google Scholar
• Mendonca LM, Machado Cda S, Teixeira CC, et al. (2015). Comparative study of curcumin and curcumin formulated in a solid dispersion: evaluation of their antigenotoxic effects. Genet Mol Biol 38:490–8
   PubMed Web of Science ®Google Scholar
• Minagawa T, Sakanaka K, Inaba S, et al. (1996). Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analog. J Pharm Pharmacol 48:1016–22
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Ranjan AP, Vishwanatha JK. (2016). Targeted nanocurcumin therapy using Annexin A2 antibody improves tumor accumulation and therapeutic efficacy against highly metastatic breast cancer. J Biomed Nanotechnol 12:1374–92
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Yu H, Kiew TY, Hadinoto K. (2015). Cost-effective alternative to nano-encapsulation: amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation. Eur J Pharm Biopharm 96:1–10
   PubMed Web of Science ®Google Scholar
• Owen H, Graham S, Werling JO, Carter PW. (2009). Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles. Int J Pharm 368:154–9
   PubMed Web of Science ®Google Scholar
• Patel VR, Agrawal YK. (2011). Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res 2:81–7
   PubMedGoogle Scholar
• Patravale VB, Date AA, Kulkarni RM. (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827–40
   PubMed Web of Science ®Google Scholar
• Peng JR, Qian ZY. (2014). Drug delivery systems for overcoming the bioavailability of curcumin: not only the nanoparticle matters. Nanomedicine (Lond) 9:747–50
   PubMed Web of Science ®Google Scholar
• Prasad S, Tyagi AK, Aggarwal BB. (2014). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46:2–18
   PubMed Web of Science ®Google Scholar
• Rabinow BE. (2004). Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–96
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–54
   PubMed Web of Science ®Google Scholar
• Singh M, Singh N. (2009). Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem 325:107–19
   PubMed Web of Science ®Google Scholar
• Soma CE, Dubernet C, Barratt G, et al. (2000). Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. J Control Release 68:283–9
   PubMed Web of Science ®Google Scholar
• Teixeira CC, Mendonca LM, Bergamaschi MM, et al. (2016). Microparticles containing curcumin solid dispersion: stability, bioavailability and anti-inflammatory activity. AAPS PharmSciTech 17:252–61
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (1998). Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 15:1–19
   PubMed Web of Science ®Google Scholar
• Tsai YM, Chien CF, Lin LC, Tsai TH. (2011). Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 416:331–8
   PubMed Web of Science ®Google Scholar
• Yuan Z, Qu X, Wang Y, et al. (2015). Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer. Colloids Surf B Biointerfaces 128:489–97
   PubMed Web of Science ®Google Scholar